Pediatrics Doctors in Highland Heights, KY Accepting Medicare

4 Pediatrics doctors found. Showing 1 - 4

Dr. Ted George Pappas, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1805 Alexandria Pike, Highland Heights, KY 41076 Phone: 859-441-7600    Fax: 859-441-7144

Dr. Victoria Renee Bobinski, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1805 Alexandria Pike, Highland Heights, KY 41076 Phone: 859-441-7600

Dr. Joan Carol Plunkett, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1805 Alexandria Pike, Highland Heights, KY 41076 Phone: 859-441-7600    Fax: 859-441-7144

Dr. Thomas Carlisle Stine, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1805 Alexandria Pike, Highland Heights, KY 41076 Phone: 859-441-7600    Fax: 859-441-7144

News Archive

Coronary stent drives Johnson & Johnson to record profits

Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.

Neurimmune Therapeutics honored with ZKB TECHNOPARK Pioneer Award

The ZKB TECHNOPARK® Pioneer Award, which has been sponsored by the Zürcher Kantonalbank since 2000, was presented for the 20th time at TECHNOPARK® Zurich. The award is given for technological innovations which - thanks to pioneering entrepreneurial achievements - are about to be launched on the market. This year's award winner is Neurimmune Therapeutics AG, represented by Dr. Jan Grimm, Professor Christoph Hock, Professor Roger Nitsch and Dr. Michael Salzmann.

Researchers find Achilles' heel of acute lymphoblastic leukemia

Researchers at The Ottawa Hospital and the University of Ottawa have found the Achilles' heel of one of the most aggressive forms of leukemia that affects both children and adults. They have also identified a possible new treatment that exploits this fatal weakness.

Research shows oral contraceptive use over three years could be a risk factor for glaucoma

Research presented today, at the 117th Annual Meeting of the American Academy of Ophthalmology in New Orleans, has found that women who have taken oral contraceptives for three or more years are twice as likely to suffer from glaucoma, one of the leading causes of blindness which affects nearly 60 million worldwide. The researchers caution gynecologists and ophthalmologists to be aware of the fact that oral contraceptives might play a role in glaucomatous diseases, and inform patients to have their eyes screened for glaucoma if they also have other risk factors.

Read more Medical News

› Verified 1 days ago